Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

published 2023-08-31 3 y ago modified 2026-06-17 4 mo ago also EUVD-2023-35483

cvss: 5.0; version 3.1, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.4%; EPSS 0.4% chance of exploitation in 30 days, percentile 37%
public exploits: 0; none known

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal.

SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details.

This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.

Patch / fix

fixed in 1

Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software 1.0.49152.778

CISA SSVC

Exploitation: none
Automatable: no
Technical impact: partial
Assessed: 2 y ago (2024-09-27)

Exploit prediction

0.43% chance of exploitation in the next 30 days, higher than 37% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
CNA	3.1	5.0	CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:N/I:H/A:N
NVD	3.1	8.1	CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Affected products

Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software

Classification

Weakness

CWE-22 Improper Limitation of a Pathname to a Restricted Directory

References

selinc.com /support/security-notifications/external-reports/
vendor-advisory
dragos.com
not-applicable

Sources

CVE List CVE-2023-31167
NVD CVE-2023-31167

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary